Prevalence of multidrug resistance tuberculosis in adult patients in India: A systematic review and meta-analysis

被引:6
作者
Charan, Jaykaran [1 ]
Tank, Nitish [5 ]
Reljic, Tea [6 ]
Singh, Surjit [1 ]
Bhardwaj, Pankaj [2 ]
Kaur, Rimplejeet [4 ]
Goyal, Jagdish P. [3 ]
Kumar, Ambuj [6 ]
机构
[1] All India Inst Med Sci, Dept Pharmacol, Jodhpur, Rajasthan, India
[2] All India Inst Med Sci, Dept Community & Family Med, Jodhpur, Rajasthan, India
[3] All India Inst Med Sci, Dept Paediat, Jodhpur, Rajasthan, India
[4] SN Med Coll & Hosp, Dept Pharmacol, Jodhpur, Rajasthan, India
[5] GMERS Med Coll, Dept Pharmacol, Himmatnagar, Gujarat, India
[6] Univ S Florida, Dept Comparat Effectiveness Res, Tampa, FL 33620 USA
关键词
India; multidrug resistance tuberculosis; prevalence; resistance; tuberculosis;
D O I
10.4103/jfmpc.jfmpc_542_19
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Multidrug resistance tuberculosis (MDR-TB) is an important public health problem for India but there is a paucity of data related to the prevalence of MDR-TB in India. This systematic review and meta-analysis was designed to synthesize evidence regarding the prevalence of MDR-TB in adult patients in India. Methods: PubMed and Google Scholar were searched to find different observational studies reporting MDR-TB prevalence in India. Data related to MDR-TB prevalence were pooled for the analysis. PubMed was searched by using different MeSH words. Prevalence was reported with 95% confidence interval (CI). A separate analysis was done for new cases and previously treated cases. Random effect model was used and heterogeneity was assessed by I2 and Cochran Q test. Results: MDR-TB prevalence in new cases were 3% (95% CI 2%-5%, I2 = 95.3%). There was difference in prevalence between different methods of measurement of MDR-TB and study designs. MDR-TB prevalence in previously treated cases was found to be 35% (95% CI 29%-41%, I2 = 98.7%). Results vary with the method of measurement as well as the study design. Conclusion: MDR-TB prevalence in previously treated patients was found higher compared to the reported values in national surveys. There is a need for large scale cross-sectional study to verify the findings observed in this review.
引用
收藏
页码:3191 / 3201
页数:11
相关论文
共 20 条
[1]   The number of privately treated tuberculosis cases in India: an estimation from drug sales data [J].
Arinaminpathy, Nimalan ;
Batra, Deepak ;
Khaparde, Sunil ;
Vualnam, Thongsuanmung ;
Maheshwari, Nilesh ;
Sharma, Lokesh ;
Nair, Sreenivas A. ;
Dewan, Puneet .
LANCET INFECTIOUS DISEASES, 2016, 16 (11) :1255-1260
[2]  
Central TB Division MoHFW Government of India, 2018, REPORT THEFIRST NATL
[3]  
Central TB Division MoHFW Government of India, 2017, TB IND 2017
[4]  
Chaudhuri A D., 2017, J Assoc Chest Physicians, V5, P1, DOI DOI 10.4103/2320-8775.196644
[5]  
Gaude Gajanan S, 2014, Niger Med J, V55, P327, DOI 10.4103/0300-1652.137194
[6]  
Glaziou P, 2015, CSH PERSPECT MED, V5, DOI [10.1101/cshperspect.a017798, 10.1055/s-0038-1651492]
[7]   Prevalence of drug-resistant pulmonary tuberculosis in India: systematic review and meta-analysis [J].
Goyal, Vishal ;
Kadam, Vijay ;
Narang, Prashant ;
Singh, Vikram .
BMC PUBLIC HEALTH, 2017, 17
[8]   The Global Fund to Fight AIDS, Tuberculosis and Malaria: 10 years on [J].
Hanefeld, Johanna .
CLINICAL MEDICINE, 2014, 14 (01) :54-57
[9]  
Hanif M, 2009, INT J TUBERC LUNG D, V13, P74
[10]   Declining trend of resistance to first-line anti-tubercular drugs in clinical isolates of Mycobacterium tuberculosis in a tertiary care north Indian hospital after implementation of revised national Tuberculosis control programme [J].
Jain, A. ;
Diwakar, P. ;
Singh, U. .
INDIAN JOURNAL OF MEDICAL MICROBIOLOGY, 2014, 32 (04) :430-433